Share This Author
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.
- E. Sonuga-Barke, D. Brandeis, J. Sergeant
- Psychology, MedicineThe American journal of psychiatry
- 1 March 2013
Better evidence for efficacy from blinded assessments is required for behavioral interventions, neurofeedback, cognitive training, and restricted elimination diets before they can be supported as treatments for core ADHD symptoms.
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
- M. Danckaerts, E. Sonuga-Barke, D. Coghill
- Psychology, MedicineEuropean Child & Adolescent Psychiatry
- 26 July 2009
In conclusion, ADHD seriously compromises QoL especially when seen from a parents’ perspective andQoL outcomes should be included as a matter of course in future treatment studies.
European clinical guidelines for hyperkinetic disorder – first upgrade
A general scheme for practice in Europe could be provided and a set of recommendations for the conceptualisation and management of hyperkinetic disorder and attention deficit/hyperactivity disorder (ADHD) are presented.
European guidelines on managing adverse effects of medication for ADHD
A guidelines group of the European Network for Hyperkinetic Disorders (EUNETHYDIS) has reviewed the literature, recruited renowned clinical subspecialists and consulted as a group to examine concerns about the safety of ADHD medications.
Practitioner review: Quality of life in child mental health--conceptual challenges and practical choices.
- D. Coghill, M. Danckaerts, E. Sonuga-Barke, J. Sergeant
- Psychology, MedicineJournal of child psychology and psychiatry, and…
- 1 May 2009
The purpose of this review is to analyse and discuss the concept of QoL and HRQoL as they relate to child and adolescent mental health, and review the various reasons for measuring QoO in this population.
Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains.
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.
A systematic review of published and unpublished data on the use of long-acting medications in ADHD and hyperkinetic disorder is reported, giving effect sizes and numbers-to-treat for…
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.
- D. Michelson, J. Buitelaar, J. Biederman
- Medicine, PsychologyJournal of the American Academy of Child and…
- 1 July 2004
In patients who responded favorably to 12 weeks of initial treatment, atomoxetine was superior to placebo in maintaining response for the ensuing 9 months, and this result supports the value of maintenance treatment with atomxetine in patients with ADHD who respond to initial treatment.
Hyperactivity and conduct problems as risk factors for adolescent development.
- E. Taylor, O. Chadwick, E. Heptinstall, M. Danckaerts
- PsychologyJournal of the American Academy of Child and…
- 1 September 1996
A developmental pathway through which hyperactivity raised the likelihood of impaired social adjustment, including the development of psychiatric disorders, independently of the existence of conduct problems was suggested.
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
- S. Cortese, M. Holtmann, J. Sergeant
- MedicineJournal of child psychology and psychiatry, and…
- 1 March 2013
Most AEs during treatment with drugs for ADHD are manageable and most of the times it is not necessary to stop medication, so that patients with ADHD may continue to benefit from the effectiveness of pharmacological treatment.